155 related articles for article (PubMed ID: 27737360)
1. Drugs or disease: evaluating salivary function in RA patients.
Torres SR; Pedrazas CH; Correia MP; Azevedo MN; Zamprogno T; Silva A; Gonçalves LS; Papi JA
Braz Oral Res; 2016 Oct; 30(1):e106. PubMed ID: 27737360
[TBL] [Abstract][Full Text] [Related]
2. Type 1 diabetes mellitus, xerostomia, and salivary flow rates.
Moore PA; Guggenheimer J; Etzel KR; Weyant RJ; Orchard T
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Sep; 92(3):281-91. PubMed ID: 11552145
[TBL] [Abstract][Full Text] [Related]
3. Association between crack cocaine use and reduced salivary flow.
Antoniazzi RP; Sari AR; Casarin M; Moraes CMB; Feldens CA
Braz Oral Res; 2017 Jun; 31():e42. PubMed ID: 28591239
[TBL] [Abstract][Full Text] [Related]
4. Salivary gland and temporomandibular joint involvement in rheumatoid arthritis: relation to disease activity.
Moen K; Bertelsen LT; Hellem S; Jonsson R; Brun JG
Oral Dis; 2005 Jan; 11(1):27-34. PubMed ID: 15641964
[TBL] [Abstract][Full Text] [Related]
5. Xerostomia, hyposalivation and oral microbiota in patients using antihypertensive medications.
Nonzee V; Manopatanakul S; Khovidhunkit SO
J Med Assoc Thai; 2012 Jan; 95(1):96-104. PubMed ID: 22379748
[TBL] [Abstract][Full Text] [Related]
6. The effects of anti-hypertensives and type 2 diabetes on salivary flow and total antioxidant capacity.
Djukić LJ; Roganović J; Brajović MD; Bokonjić D; Stojić D
Oral Dis; 2015 Jul; 21(5):619-25. PubMed ID: 25689395
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of salivary function in patients with burning mouth syndrome.
Lee YC; Hong IK; Na SY; Eun YG
Oral Dis; 2015 Apr; 21(3):308-13. PubMed ID: 24962264
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant chemotherapy in breast cancer patients induces temporary salivary gland hypofunction.
Jensen SB; Mouridsen HT; Reibel J; Brünner N; Nauntofte B
Oral Oncol; 2008 Feb; 44(2):162-73. PubMed ID: 17588802
[TBL] [Abstract][Full Text] [Related]
9. Salivary levels of cortisol and chromogranin A in patients with dry mouth compared with age-matched controls.
Shigeyama C; Ansai T; Awano S; Soh I; Yoshida A; Hamasaki T; Kakinoki Y; Tominaga K; Takahashi T; Takehara T
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Dec; 106(6):833-9. PubMed ID: 18755621
[TBL] [Abstract][Full Text] [Related]
10. A reference guide to drugs and dry mouth--2nd edition.
Sreebny LM; Schwartz SS
Gerodontology; 1997 Jul; 14(1):33-47. PubMed ID: 9610301
[TBL] [Abstract][Full Text] [Related]
11. Are salivary flow rates associated with histopathologic aspects in patients with rheumatoid arthritis?
Helms JBDS; Barbosa CA; Abrahão AC; Cabral MG; Bica BERG; Torres SR
Braz Oral Res; 2022; 36():e0120. PubMed ID: 36228219
[TBL] [Abstract][Full Text] [Related]
12. Risk factors, hyposalivation and impact of xerostomia on oral health-related quality of life.
Niklander S; Veas L; Barrera C; Fuentes F; Chiappini G; Marshall M
Braz Oral Res; 2017 Jan; 31():e14. PubMed ID: 28099580
[TBL] [Abstract][Full Text] [Related]
13. The effect of toothpicks containing flavoring and flavoring plus jambu extract (spilanthol) to promote salivation in patients -diagnosed with opioid-induced dry mouth (xerostomia).
Davis B; Davis K; Bigelow S; Healey P
J Opioid Manag; 2017; 13(5):335-340. PubMed ID: 29199399
[TBL] [Abstract][Full Text] [Related]
14. The relation between xerostomia and hyposalivation in subjects with rheumatoid arthritis or fibromyalgia.
Nederfors T; Holmström G; Paulsson G; Sahlberg D
Swed Dent J; 2002; 26(1):1-7. PubMed ID: 12090156
[TBL] [Abstract][Full Text] [Related]
15. Xerostomia: prevalence and pharmacotherapy. With special reference to beta-adrenoceptor antagonists.
Nederfors T
Swed Dent J Suppl; 1996; 116():1-70. PubMed ID: 8813731
[TBL] [Abstract][Full Text] [Related]
16. Small salivary gland size in patients with xerostomia of unknown etiology.
Ono K; Tanaka T; Inoue H; Ansai T; Sato-Wakasugi N; Muraoka K; Yokota M; Takehara N; Morimoto Y; Inenaga K
Arch Oral Biol; 2009 Apr; 54(4):369-73. PubMed ID: 19185851
[TBL] [Abstract][Full Text] [Related]
17. Hyposalivation, xerostomia and oral health status of HIV-infected subjects in Thailand before HAART era.
Nittayananta W; Chanowanna N; Jealae S; Nauntofte B; Stoltze K
J Oral Pathol Med; 2010 Jan; 39(1):28-34. PubMed ID: 19709350
[TBL] [Abstract][Full Text] [Related]
18. A characterization of major salivary gland flow rates in the presence of medications and systemic diseases.
Wu AJ; Ship JA
Oral Surg Oral Med Oral Pathol; 1993 Sep; 76(3):301-6. PubMed ID: 8378045
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic performance of labial minor salivary gland flow measurement for assessment of xerostomia.
Satoh-Kuriwada S; Iikubo M; Shoji N; Sakamoto M; Sasano T
Arch Oral Biol; 2012 Aug; 57(8):1121-6. PubMed ID: 22673753
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and factors associated with xerostomia and hyposalivation among community-dwelling older people in Japan.
Ohara Y; Hirano H; Yoshida H; Obuchi S; Ihara K; Fujiwara Y; Mataki S
Gerodontology; 2016 Mar; 33(1):20-7. PubMed ID: 24304087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
